MY185464A - Complement component c5 irna compositions and methods of use thereof - Google Patents

Complement component c5 irna compositions and methods of use thereof

Info

Publication number
MY185464A
MY185464A MYPI2015002325A MYPI2015002325A MY185464A MY 185464 A MY185464 A MY 185464A MY PI2015002325 A MYPI2015002325 A MY PI2015002325A MY PI2015002325 A MYPI2015002325 A MY PI2015002325A MY 185464 A MY185464 A MY 185464A
Authority
MY
Malaysia
Prior art keywords
complement component
methods
irna
compositions
irna compositions
Prior art date
Application number
MYPI2015002325A
Inventor
Kevin Fitzgerald
James Butler
Brian Bettencourt
Anna Borodovsky
Satyanarayana Kuchimanchi
Klaus Charisse
Muthiah Manoharan
Martin Maier
Rajeev G Kallanthottathil
Donald Foster
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Priority claimed from PCT/US2014/025882 external-priority patent/WO2014160129A2/en
Publication of MY185464A publication Critical patent/MY185464A/en

Links

Abstract

The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the complement component C5 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of C5 and to treat subjects having a complement component C5-associated disease, e.g., paroxysmal nocturnal hemoglobinuria.
MYPI2015002325A 2013-03-14 2014-03-13 Complement component c5 irna compositions and methods of use thereof MY185464A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361782531P 2013-03-14 2013-03-14
US201361837399P 2013-06-20 2013-06-20
US201361904579P 2013-11-15 2013-11-15
PCT/US2014/025882 WO2014160129A2 (en) 2013-03-14 2014-03-13 Complement component c5 irna compositions and methods of use thereof

Publications (1)

Publication Number Publication Date
MY185464A true MY185464A (en) 2021-05-19

Family

ID=87846572

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015002325A MY185464A (en) 2013-03-14 2014-03-13 Complement component c5 irna compositions and methods of use thereof

Country Status (1)

Country Link
MY (1) MY185464A (en)

Similar Documents

Publication Publication Date Title
MX2019008380A (en) Complement component c5 irna compositions and methods of use thereof.
MX2021006052A (en) Complement component irna compositions and methods of use thereof.
WO2016201301A8 (en) Complement component c5 irna compositions and methods of use thereof
MX2019006413A (en) Serpinc1 irna compositions and methods of use thereof.
MX2018006989A (en) Methods and compositions for treating a serpinc1-associated disorder.
WO2017019660A8 (en) Xanthine dehydrogenase (xdh) irna compositions and methods of use thereof
PH12017500669A1 (en) Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
MX2021000656A (en) SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF.
MX2019012252A (en) Compositions and methods for inhibiting expression of the alas1 gene.
MY181888A (en) Tmprss6 irna compositions and methods of use thereof
MX2021010716A (en) Compositions and methods for inhibiting expression of the lect2 gene.
MX2022001017A (en) Compositions and methods for inhibiting expression of the alas1 gene.
MY185464A (en) Complement component c5 irna compositions and methods of use thereof
IN2015DN02699A (en)
AR127877A2 (en) RNAi COMPOSITIONS OF COMPLEMENT C5 COMPONENT AND METHODS FOR ITS USE
EA037110B9 (en) PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF